Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes | NEJM - discu.eu

Reddit

Cardiovascular disease is the leading cause of death and complications in patients with type 2 diabetes. A new clinical trial reveals once weekly injection of a GLP1 analogue reduces this risk by 26%. http://www.nejm.org/doi/full/10.1056/nejmoa1607141#t=abstract 7 comments 5/2/2017 science

Linking pages

What we still don’t know about Wegovy’s effect on strokes and heart attacks https://www.sciencenews.org/article/semaglutide-wegovy-ozempic-strokes-heart 2 comments

Linked pages

Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2208375 145 comments

Related searches:

Search whole site: site:www.nejm.org

Search title: Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes | NEJM

See how to search.

Submit link to: